Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - INNOVATIVE MEDICINE “F-627 (EFBEMALENOGRASTIM ALFA INJECTION)” APPROVED FOR MARKETING2023.05.09
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 20232023.05.05
-
2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT2023.04.28
-
2022 ANNUAL REPORT2023.04.28
-
(1) GENERAL MANDATES TO ISSUE AND BUY BACK SHARES; (2) RE-ELECTION OF DIRECTORS; (3) ADOPTION OF SHARE OPTION SCHEME; AND (4) NOTICE OF ANNUAL GENERAL MEETING2023.04.28
-
NOTICE OF ANNUAL GENERAL MEETING2023.04.28
-
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)2023.04.28
-
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS2023.04.28